Carl O’Hara
- Molecular Biology top 5%
- Oncology top 1%
- Epidemiology top 2%
- Immunology top 2%
- Pathology and Forensic Medicine top 1%
- Co-authors
- David C. SeldinMartha SkinnerVaishali SanchorawalaJohn L. BerkRodney H. FalkDaniel G. WrightNiall SwanJerome E. Groopman
- Topics
- Amyloidosis: Diagnosis, Treatment, Outcomes (33 papers)Monoclonal and Polyclonal Antibodies Research (13 papers)Lymphoma Diagnosis and Treatment (11 papers)
- Cited by
- VirologyOncologyNephrology
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Carl O’Hara
108 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Molecular Biology 2.3k
- Oncology 1.8k
- Epidemiology 1.0k
- Immunology 1.0k
- Pathology and Forensic Medicine 943
Countries citing papers authored by Carl O’Hara
This map shows the geographic impact of Carl O’Hara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl O’Hara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl O’Hara more than expected).
Fields of papers citing papers by Carl O’Hara
This network shows the impact of papers produced by Carl O’Hara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl O’Hara. The network helps show where Carl O’Hara may publish in the future.
Co-authorship network of co-authors of Carl O’Hara
This figure shows the co-authorship network connecting the top 25 collaborators of Carl O’Hara. A scholar is included among the top collaborators of Carl O’Hara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl O’Hara. Carl O’Hara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 15 | |
| 3 | 3 | |
| 4 | 19 | |
| 5 | 4 | |
| 6 | 7 | |
| 7 | 118 | |
| 8 | 36 | |
| 9 | 7 | |
| 10 | 25 | |
| 11 | 12 | |
| 12 | 99 | |
| 13 | 331 | |
| 14 | 106 | |
| 15 | 19 | |
| 16 | 1 | |
| 17 | 16 | |
| 18 | Expression of Epstein–Barr Virus Transformation–Associated Genes in Tissues of Patients with EBV Lymphoproliferative Diseasebreakdown → | 660 |
| 19 | 23 | |
| 20 | 5 |
About Carl O’Hara
Carl O’Hara is a scholar working on Genetics, Oncology and Immunology, having authored 108 papers that have together received 5.8k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (33 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Lymphoma Diagnosis and Treatment (11 papers). The work is most often cited by research in Virology (750 citations), Oncology (1.8k citations) and Nephrology (400 citations). Carl O’Hara has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include David C. Seldin, Martha Skinner, Vaishali Sanchorawala, John L. Berk, Rodney H. Falk, Daniel G. Wright, Niall Swan, Jerome E. Groopman, Elliott Kieff and Lawrence S. Young. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.